GENE ONLINE|News &
Opinion
Blog

2018-05-22|

May 22, 1989: NCI’s First Attempt to Genetically Engineer and Modify the Ability of Human Lymphocyte

by GeneOnline
Share To

On May 22, 1989, Dr. Steven A. Rosenberg, a scientist at the National Cancer Institute (NCI), performed the first human gene transfer trial in the history. Dr. Rosenberg implanted the human tumor-infiltrating lymphocytes with a foreign bacterial gene added to human body, and attempted to use genetic engineering to enhance the tracking and cytophagic abilities of lymphocytes.

Reference
https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Efficient Phage Production System Promises Win Against Superbugs
2022-07-20
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
AACR 2022 Opening: Decoding Cancer Complexity to Transform Patient Outcomes
2022-04-12
LATEST
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Ways to Reduce Carbon Emission in Cement Manufacturing
2023-03-26
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Scroll to Top